DDrare: Database of Drug Development for Rare Diseases

159. 色素性乾皮症
［臨床試験数：5，薬物数：13（DrugBank：4），標的遺伝子数：4，標的パスウェイ数：13］

Searched query = "Xeroderma pigmentosum", "XP"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = Ipilimumab; Isotretinoin; Liposomal T4N5 lotion; Nivolumab; Procedure: Biospecimen Collection; TRABECTEDINA; Trabectedina; Trabectedine; YONDELIS 0,25 mg polvo para concentrado para solución para perfusión; YONDELIS 1 mg polvo para concentrado para solución para perfusión; Yondelis; Yondelis 0.25 mg powder for concentrate for solution for infusion.; Yondelis 1 mg powder for concentrate for solution for infusion.

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00025012 (ClinicalTrials.gov)	June 1991	11/10/2001	Isotretinoin in Preventing Skin Cancer	Use Of Isotretinion For Prevention Of Skin Cancer In Patients With Xeroderma Pigmentosum Or Nevoid Basal Cell Carcinoma Syndrome	Melanoma (Skin);Non-melanomatous Skin Cancer	Drug: isotretinoin	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	NULL	Completed	2 Years	N/A	Both		N/A	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00025012
(ClinicalTrials.gov)

June 1991

11/10/2001

Isotretinoin in Preventing Skin Cancer

Use Of Isotretinion For Prevention Of Skin Cancer In Patients With Xeroderma Pigmentosum Or Nevoid Basal Cell Carcinoma Syndrome

Melanoma (Skin);Non-melanomatous Skin Cancer

Drug: isotretinoin

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NULL

Completed

2 Years

N/A

Both

N/A

United States